New Combination of Pills Cure Hepatitis C Patients: Study

A combination of pills that cures 9 of 10 hepatitis C patients and is well tolerated by patients, reveals a new study.

Researchers from the University of Texas Health Science Center at San Antonio found the combination of the drugs sofosbuvir and simeprevir, with or without ribavirin that cured 93 percent of patients in 12 weeks.

Lead researcher, Eric Lawitz, said that they were now in the midst of a paradigm shift of moving away from complicated injection regimens that included interferon and often caused significant side effects with modest success rates.

Lawitz added that this trial provided a glimpse into the outcomes of sofosbuvir and simeprevir for treatment of hepatitis C and both drugs were approved by the FDA but were not yet approved together for this treatment.

This study is published in The Lancet.

Source: ANI

Study Identifies Hepatitis C Virus Genotype 1 as the Most Prevalent Worldwide

British researchers have found that genotype 1 is the most prevalent hepatitis C virus (HCV) worldwide.

Hardest-To-Treat Hepatitis C Now Curable With New Oral Drug Regimens

Shorter and more effective treatment options for hepatitis C with two new pill-only antiviral drug regimens is now available.

Eliminating Hepatitis C Virus can Provide Economic Benefits and Improve Healthcare Disparities

Stating that the elimination of hepatitis c virus infection is feasible, The Miriam Hospital's Lynn Taylor said that it can also lead to economic benefits.

New Study Offers Hope for HIV and Hepatitis C Patients

A new study says novel hepatitis C drug has shown early promise in patients whose infection with both HIV and hepatitis C has made them traditionally difficult to treat.

Aplastic Anemia

Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blood cells.

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Hepatitis A

Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. Hepatitis A vaccine is available that is 95% effective in preventing the disease.